JANUX THERAPEUTICS INC shareholders Q2 2023

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 55 filers reported holding JANUX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

JANUX THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
GEODE CAPITAL MANAGEMENT, LLC 377,225$4,477,6600.00%
DekaBank Deutsche Girozentrale 49,500$5710.00%
Qube Research & Technologies Ltd 12,641$150,0490.00%
Swiss National Bank 22,800$270,6360.00%
US BANCORP \DE\ 90$1,0680.00%
BARCLAYS PLC 5,479$650.00%
BANK OF AMERICA CORP /DE/ 21,147$251,0160.00%
Russell Investments Group, Ltd. 1,532$18,1840.00%
JPMORGAN CHASE & CO 153,436$1,821,2860.00%
WELLS FARGO & COMPANY/MN 6,633$78,7340.00%
NORTHERN TRUST CORP 187,290$2,223,1320.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Legal & General Group Plc 10,194$121,0040.00%
Renaissance Technologies 14,800$1760.00%
STATE STREET CORP 332,590$3,947,8430.00%
Nuveen Asset Management, LLC 58,745$697,3030.00%
VANGUARD GROUP INC 761,990$9,044,8200.00%
NEW YORK STATE COMMON RETIREMENT FUND 5,030$600.00%
DEUTSCHE BANK AG\ 6,973$82,7700.00%
CREDIT SUISSE AG/ 15,899$188,7210.00%
External links

This page lists JANUX THERAPEUTICS INC's shareholders in Q2 2023. To view JANUX THERAPEUTICS INC's shareholder history, click here.